(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are FIRST REPUBLIC BANK, Riot Blockchain, and Canaan.

The three biggest losers today are Western Alliance Bancorporation, Aspen Group, and AMC.

Winners today

1. FIRST REPUBLIC BANK (FRC) – 21.61%

First Republic Bank, together with its subsidiaries, provides private banking, private business banking, and private wealth management services to clients in metropolitan areas in the United States. It operates in two segments, Commercial Banking and Wealth Management. The company accepts deposit products, such as noninterest-bearing checking, interest-bearing checking, money market checking accounts, money market savings accounts, and passbook accounts, as well as certificates of deposit. It also offers a range of lending products that comprise residential mortgage loans, home equity lines of credit, multifamily loans, commercial real estate and construction loans, personal and business loans, single family construction loans, and other loans and lines of credit to businesses and individuals. The company's loans are secured by single family residences, multifamily buildings, and commercial real estate properties. In addition, it provides wealth management services, which include various investment strategies and products, online investment management, trust and custody, full service and online brokerage, financial and estate planning, and access to alternative investments, as well as investing, insurance, and foreign exchange services. Further, the company offers online and mobile banking services; refinancing services; and ATM and debit cards. As of December 31, 2021, it offered its services through 82 licensed deposit taking offices primarily in the San Francisco, Palo Alto, Los Angeles, Santa Barbara, Newport Beach and San Diego, California; Portland, Oregon; Boston, Massachusetts; Palm Beach, Florida; Greenwich, Connecticut; New York, New York; and Jackson, Wyoming. It also has 12 additional offices that offer lending, wealth management, or trust services. First Republic Bank was founded in 1985 and is headquartered in San Francisco, California.

NYSE ended the session with FIRST REPUBLIC BANK jumping 21.61% to $37.96 on Tuesday while NYSE rose 1.22% to $14,944.74.

Earnings Per Share

As for profitability, FIRST REPUBLIC BANK has a trailing twelve months EPS of $6.4.

PE Ratio

FIRST REPUBLIC BANK has a trailing twelve months price to earnings ratio of 5.93. Meaning, the purchaser of the share is investing $5.93 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.99%.

Sales Growth

FIRST REPUBLIC BANK’s sales growth is negative 1.4% for the current quarter and negative 8% for the next.

Yearly Top and Bottom Value

FIRST REPUBLIC BANK’s stock is valued at $37.96 at 17:32 EST, way below its 52-week low of $45.00.

More news about FIRST REPUBLIC BANK.

2. Riot Blockchain (RIOT) – 10.24%

Riot Platforms, Inc., together with its subsidiaries, focuses on bitcoin mining operations in North America. It operates through Bitcoin Mining, Data Center Hosting, and Electrical Products and Engineering segments. As of December 31, 2021, it operated approximately 30,907 miners. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is headquartered in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain rising 10.24% to $6.89 on Tuesday while NASDAQ rose 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -36.07%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 28.6%, now sitting on 289.91M for the twelve trailing months.

Sales Growth

Riot Blockchain’s sales growth is negative 39.1% for the current quarter and negative 10.4% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 28.6% and a drop 126.7% for the next.

More news about Riot Blockchain.

3. Canaan (CAN) – 9.86%

Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components primarily in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has a strategic cooperation with Northern Data AG in the areas of artificial intelligence development, blockchain technology, and datacenter operations. Canaan Inc. was founded in 2013 and is based in Beijing, the People's Republic of China.

NASDAQ ended the session with Canaan jumping 9.86% to $2.83 on Tuesday, following the last session’s upward trend. NASDAQ jumped 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Canaan has a trailing twelve months EPS of $-0.212.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 62.53%.

Sales Growth

Canaan’s sales growth for the next quarter is negative 86.3%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be oversold (<=20).

Volatility

Canaan’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.24%, a negative 0.71%, and a positive 5.03%.

Canaan’s highest amplitude of average volatility was 5.60% (last week), 4.34% (last month), and 5.03% (last quarter).

More news about Canaan.

4. Charles Schwab (SCHW) – 9.67%

The Charles Schwab Corporation, together with its subsidiaries, provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. The company operates in two segments, Investor Services and Advisor Services. The Investor Services segment provides retail brokerage, investment advisory, banking and trust, retirement plan, and other corporate brokerage services; equity compensation plan sponsors full-service recordkeeping for stock plans, stock options, restricted stock, performance shares, and stock appreciation rights; and retail investor and mutual fund clearing services, as well as compliance solutions. The Advisor Services segment offers custodial, trading, banking, and support services; and retirement business and corporate brokerage retirement services. This segment provides brokerage accounts with equity and fixed income, margin lending, options, and futures and forex trading; cash management capabilities comprising third-party certificates of deposit; third-party and proprietary mutual funds; plus mutual fund trading and clearing services; and exchange-traded funds (ETFs), including proprietary and third-party ETFs. It also offers advice solutions, such as managed portfolios of proprietary and third-party mutual funds and ETFs, separately managed accounts, customized personal advice for tailored portfolios, and specialized planning and portfolio management. In addition, this segment provides banking products and services, including checking and savings accounts, first lien residential real estate mortgage loans, home equity lines of credit, and pledged asset lines; and trust services comprising trust custody services, personal trust reporting services, and administrative trustee services. As of December 31, 2021, the Company had approximately 400 domestic branch offices in 48 states and the District of Columbia, as well as locations in Puerto Rico, the United Kingdom, Hong Kong, and Singapore. The Charles Schwab Corporation was incorporated in 1971 and is headquartered in Westlake, Texas.

NYSE ended the session with Charles Schwab rising 9.67% to $56.93 on Tuesday, after five successive sessions in a row of losses. NYSE rose 1.22% to $14,944.74, after three sequential sessions in a row of losses, on what was an all-around up trend exchanging session today.

Earnings Per Share

As for profitability, Charles Schwab has a trailing twelve months EPS of $2.32.

PE Ratio

Charles Schwab has a trailing twelve months price to earnings ratio of 24.56. Meaning, the purchaser of the share is investing $24.56 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.4%.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 8, 2023, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1.24%.

Yearly Top and Bottom Value

Charles Schwab’s stock is valued at $56.93 at 17:32 EST, below its 52-week low of $57.31.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Charles Schwab’s stock is considered to be overbought (>=80).

Sales Growth

Charles Schwab’s sales growth is 15.9% for the current quarter and 8.1% for the next.

More news about Charles Schwab.

5. Unum Group (UNM) – 8.9%

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, and Poland. It operates through Unum US, Unum International, Colonial Life, and Closed Block segments. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products. It also provides group pension, individual life and corporate-owned life insurance, reinsurance pools and management operations, and other products. The company sells its products primarily to employers for the benefit of employees. Unum Group sells its products through field sales personnel, independent brokers, consultants, and independent contractor agency sales force. The company was founded in 1848 and is based in Chattanooga, Tennessee.

NYSE ended the session with Unum Group rising 8.9% to $39.90 on Tuesday while NYSE jumped 1.22% to $14,944.74.

Earnings Per Share

As for profitability, Unum Group has a trailing twelve months EPS of $3.89.

PE Ratio

Unum Group has a trailing twelve months price to earnings ratio of 10.26. Meaning, the purchaser of the share is investing $10.26 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.75%.

Moving Average

Unum Group’s value is below its 50-day moving average of $42.13 and above its 200-day moving average of $39.36.

Volume

Today’s last reported volume for Unum Group is 3518100 which is 132.89% above its average volume of 1510610.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 15.4% and a drop 15.7% for the next.

More news about Unum Group.

6. Aceto Corporation (ACET) – 8.26%

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase 1 clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors, including hepatocellular carcinoma, gastric cancer, and squamous cell carcinoma of the lung. The company is based in Boston, Massachusetts.

NASDAQ ended the session with Aceto Corporation rising 8.26% to $7.73 on Tuesday, following the last session’s upward trend. NASDAQ jumped 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Earnings Per Share

As for profitability, Aceto Corporation has a trailing twelve months EPS of $-1.33.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -20.84%.

More news about Aceto Corporation.

7. Xenetic Biosciences (XBIO) – 7.94%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. It is also leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, PJSC Pharmsynthez, and SynBio LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences rising 7.94% to $0.38 on Tuesday, after five successive sessions in a row of losses. NASDAQ jumped 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-1.704.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.85%.

Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.38 at 17:32 EST, way below its 52-week high of $1.25 and way above its 52-week low of $0.24.

More news about Xenetic Biosciences.

8. Castle Biosciences (CSTL) – 7.75%

Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma and myPath Melanoma, a proprietary GEP test to diagnose suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.

NASDAQ ended the session with Castle Biosciences jumping 7.75% to $21.54 on Tuesday while NASDAQ rose 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Castle Biosciences has a trailing twelve months EPS of $-1.24.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.86%.

Volume

Today’s last reported volume for Castle Biosciences is 168588 which is 5.45% above its average volume of 159862.

More news about Castle Biosciences.

9. Fifth Third Bancorp (FITBI) – 7.46%

Fifth Third is a bank that's as long on innovation as it is on history. Since 1858, we've been helping individuals, families, businesses and communities grow through smart financial services that improve lives. Our list of firsts is extensive, and it's one that continues to expand as we explore the intersection of tech-driven innovation, dedicated people, and focused community impact. Fifth Third is one of the few U.S.-based banks to have been named among Ethisphere's World's Most Ethical Companies® for several years. With a commitment to taking care of our customers, employees, communities and shareholders, our goal is not only to be the nation's highest performing regional bank, but to be the bank people most value and trust. Fifth Third Bank, National Association is a federally chartered institution. Fifth Third Bancorp is the indirect parent company of Fifth Third Bank and its common stock is traded on the NASDAQ® Global Select Market under the symbol “FITB.” Investor information and press releases can be viewed at www.53.com.

NASDAQ ended the session with Fifth Third Bancorp jumping 7.46% to $23.20 on Tuesday while NASDAQ jumped 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Fifth Third Bancorp has a trailing twelve months EPS of $2.72.

PE Ratio

Fifth Third Bancorp has a trailing twelve months price to earnings ratio of 8.52. Meaning, the purchaser of the share is investing $8.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.37%.

More news about Fifth Third Bancorp.

10. Aware, Inc. (AWRE) – 7.02%

Aware, Inc. provides biometrics software products and solutions in the United States, Brazil, the United Kingdom, and internationally. It offers biometrics software products, including biometric search and matching software development kits (SDKs); biometric enrollment SDKs and application programming interfaces (APIs); and imaging products for medical and advanced imaging applications, such as JPEG2000 product to compress, store, and display images, as well as software maintenance services. The company also provides Knomi mobile biometric authentication framework; AwareABIS, an automated biometric identification system; AFIX suite of products for small-scale law enforcement focused biometric identification; BioSP, a biometric services platform; WebEnroll, a browser-based biometric enrollment and data management solution; AwareID, a software-as-a-service that provides biometric face and voice analysis for liveness-verification, and document validation; and Fortress Identity Biometric Authenticator and Onboarding Authentication Platform, which offers multi-factor authentication through passive and active biometrics for multiple modalities, including voice, fingerprint, face, and behavior to enable online onboarding and identity proofing. In addition, it offers program management and software engineering services, including project planning and management; system and architecture design; software design, development, customization, configuration, and testing; and software integration and installation. The company's software portfolio enables government agencies and commercial entities to enroll, identify, authenticate, and enable using biometrics, such as fingerprints, faces, irises, and voices. The company sells its products through systems integrators, original equipment manufacturers, value added resellers, and partners, as well as directly to end user customers. Aware, Inc. was incorporated in 1986 and is headquartered in Burlington, Massachusetts.

NASDAQ ended the session with Aware, Inc. rising 7.02% to $1.83 on Tuesday, after four successive sessions in a row of losses. NASDAQ rose 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Aware, Inc. has a trailing twelve months EPS of $-0.373.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.89%.

Moving Average

Aware, Inc.’s value is above its 50-day moving average of $1.71 and under its 200-day moving average of $1.97.

Sales Growth

Aware, Inc.’s sales growth is negative 22.4% for the present quarter and negative 38.2% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Aware, Inc.’s stock is considered to be overbought (>=80).

More news about Aware, Inc..

Losers Today

1. Western Alliance Bancorporation (WAL) – -47.06%

Western Alliance Bancorporation operates as the bank holding company for Western Alliance Bank that provides various banking products and related services primarily in Arizona, California, and Nevada. It operates in Commercial, Consumer Related, and Corporate & Other segments. The company offers deposit products, including checking, savings, and money market accounts, as well as fixed-rate and fixed maturity certificates of deposit accounts; and treasury management and residential mortgage products and services. It also offers commercial and industrial loan products, such as working capital lines of credit, loans to technology companies, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans; commercial real estate loans, which are secured by multi-family residential properties, professional offices, industrial facilities, retail centers, hotels, and other commercial properties; construction and land development loans for single family and multi-family residential projects, industrial/warehouse properties, office buildings, retail centers, medical office facilities, and residential lot developments; and consumer loans. In addition, the company provides other financial services, such as internet banking, wire transfers, electronic bill payment and presentment, lock box services, courier, and cash management services. Further, it holds certain investment securities, municipal and non-profit loans, and leases; invests primarily in low-income housing tax credits and small business investment corporations; and holds certain real estate loans and related securities. The company operates 36 branch locations, as well as loan production offices. Western Alliance Bancorporation was founded in 1994 and is headquartered in Phoenix, Arizona.

NYSE ended the session with Western Alliance Bancorporation sliding 47.06% to $26.12 on Tuesday, after five consecutive sessions in a row of losses. NYSE rose 1.22% to $14,944.74, after three successive sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Western Alliance Bancorporation has a trailing twelve months EPS of $6.12.

PE Ratio

Western Alliance Bancorporation has a trailing twelve months price to earnings ratio of 4.27. Meaning, the purchaser of the share is investing $4.27 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.49%.

Moving Average

Western Alliance Bancorporation’s worth is way below its 50-day moving average of $69.69 and way under its 200-day moving average of $71.06.

More news about Western Alliance Bancorporation.

2. Aspen Group (ASPU) – -17.65%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group dropping 17.65% to $0.14 on Tuesday while NASDAQ jumped 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.383.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.28%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 9.9%, now sitting on 74.29M for the twelve trailing months.

Moving Average

Aspen Group’s worth is way below its 50-day moving average of $0.26 and way under its 200-day moving average of $0.58.

More news about Aspen Group.

3. AMC (AMC) – -15.53%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. The company owns, operates, or has interests in theatres in the United States and Europe. As of March 1, 2022, it operated approximately 950 theatres and 10,600 screens. The company was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC falling 15.53% to $4.61 on Tuesday, after two successive sessions in a row of gains. NYSE rose 1.22% to $14,944.74, after three sequential sessions in a row of losses, on what was an all-around up trend trading session today.

: AMC shareholders approve ‘ape’ conversionAMC Entertainment Holdings Inc.’s AMC shareholders have approved the company’s proposal to convert AMC Preferred Equity APE unitsinto shares of common stock. , In January, AMC announced the special meeting of shareholders to increase the number of AMC-authorized shares from just over 524 million to 550 million and to authorize a 1-for-10 reverse split of the company’s common stock, converting APEs into shares common stock.

AMC shareholders approve conversion of 'ape' preferred equity into common stockAMC Entertainment Holdings Inc.’s AMC shareholders have approved the company’s proposal to convert AMC Preferred Equity APE unitsinto shares of common stock. , In January, AMC announced the special meeting of shareholders to increase the number of AMC-authorized shares from just over 524 million to 550 million and to authorize a 1-for-10 reverse split of the company’s common stock, converting APEs into shares common stock.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-39.152.

Previous days news about AMC

• : AMC networks’ kristin dolan has resigned from company board. According to MarketWatch on Monday, 13 March, "The company – which oversees TV channels like AMC and IFC – said in a filing that the resignation was "not the result of any dispute or disagreement with the Company or the Company’s Board of Directors on any matter relating to the operations, policies, or practices of the Company." AMC Networks named Dolan as its new chief executive last month. "

More news about AMC.

4. Webster Financial Corporation (WBS) – -12.74%

Webster Financial Corporation operates as the bank holding company for Webster Bank, National Association that provides a range of banking, investment, and financial services to individuals, families, and businesses in the United States. It operates through three segments: Commercial Banking, HSA Bank, and Community Banking. The Commercial Banking segment provides lending, deposit, and cash management services to middle market companies; and commercial and industrial lending and leasing, commercial real estate lending, equipment financing, and asset-based lending, as well as treasury and payment services. This segment also offers asset management, financial planning and trust services, and deposit and loan products for high net worth clients, not-for-profit organizations, and business clients. The HSA Bank segment offers health savings accounts, health reimbursement accounts, flexible spending accounts, and other financial solutions to employers for the benefit of their employees and individuals. The Community Banking segment offers deposit and fee-based services, residential mortgages, home equity lines or loans, unsecured consumer loans, and credit cards to consumers, as well as investment and securities-related services, including brokerage and investment advice through a strategic partnership with LPL Financial Holdings Inc. This segment also provides credit, deposit, and cash flow management products to businesses and professional service firms. The company also offers online and mobile banking services. As of February 12, 2021, it operated 155 banking centers and 297 ATMs. Webster Financial Corporation was founded in 1935 and is headquartered in Waterbury, Connecticut.

NYSE ended the session with Webster Financial Corporation sliding 12.74% to $37.55 on Tuesday while NYSE rose 1.22% to $14,944.74.

Earnings Per Share

As for profitability, Webster Financial Corporation has a trailing twelve months EPS of $3.54.

PE Ratio

Webster Financial Corporation has a trailing twelve months price to earnings ratio of 10.61. Meaning, the purchaser of the share is investing $10.61 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.21%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 99.3%, now sitting on 2.19B for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 31.5% and 31.8%, respectively.

Moving Average

Webster Financial Corporation’s value is way below its 50-day moving average of $50.42 and way under its 200-day moving average of $48.49.

More news about Webster Financial Corporation.

5. Ameris Bancorp (ABCB) – -12.51%

Ameris Bancorp operates as the bank holding company for Ameris Bank that provides range of banking services to retail and commercial customers primarily in Georgia, Alabama, Florida, and South Carolina. The company operates through five segments: Banking Division, Retail Mortgage Division, Warehouse Lending Division, SBA Division, and Premium Finance Division. It offers commercial and retail checking, regular interest-bearing savings, money market, individual retirement, and certificates of deposit accounts. The company also provides commercial real estate, residential real estate mortgage, agricultural, and commercial and industrial loans; consumer loans, including motor vehicle, home improvement, and home equity loans, as well as loans secured by savings accounts and small unsecured personal credit lines. In addition, it originates, administers, and services commercial insurance premium loans and small business administration loans. The company operates 164 full service domestic banking offices and 33 mortgage and loan production offices. Ameris Bancorp was founded in 1971 and is headquartered in Atlanta, Georgia.

NASDAQ ended the session with Ameris Bancorp sliding 12.51% to $37.14 on Tuesday, following the last session’s downward trend. NASDAQ rose 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around bullish trend trading session today.

Earnings Per Share

As for profitability, Ameris Bancorp has a trailing twelve months EPS of $4.99.

PE Ratio

Ameris Bancorp has a trailing twelve months price to earnings ratio of 7.44. Meaning, the purchaser of the share is investing $7.44 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.24%.

More news about Ameris Bancorp.

6. Acorn Energy (ACFN) – -10.26%

Acorn Energy, Inc., through its subsidiaries, develops and markets wireless remote monitoring and control systems for various markets in the United States and internationally. It operates through two segments, Power Generation (PG) Monitoring and Cathodic Protection (CP) Monitoring. The PG segment provides wireless remote monitoring and control systems, and services for critical assets, which include stand-by power generators, compressors, pumps, pumpjacks, light towers, turbines, and other industrial equipment; and Internet of Things applications. The CP segment offers remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies. The company was incorporated in 1986 and is based in Wilmington, Delaware.

NASDAQ ended the session with Acorn Energy dropping 10.26% to $0.35 on Tuesday while NASDAQ jumped 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Acorn Energy has a trailing twelve months EPS of $-0.01.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.5%, now sitting on 6.91M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Acorn Energy’s EBITDA is -96.52.

Moving Average

Acorn Energy’s value is higher than its 50-day moving average of $0.35 and way below its 200-day moving average of $0.43.

More news about Acorn Energy.

7. Unisys Corporation New (UIS) – -10.22%

Unisys Corporation, together with its subsidiaries, operates as an information technology services company worldwide. It operates in Digital Workplace Solutions (DWS); Cloud and Infrastructure Solutions (C&I); and Enterprise Computing Solutions (ECS) segments. The DWS segment provides solutions that transform digital workplaces securely and create exceptional end-user experiences. The C&I segment offers solutions that drive modern IT service platforms, cloud applications development, intelligent services, and cybersecurity services. The ECS segment provides solutions that harness secure, continuous high-intensity computing, and enable digital services through software-defined operating environments. Its solutions include Unisys InteliServe, a service solution that transforms traditional service desk into an intelligent, user-centric experience aligned with the needs of the modern digital workplace; Unisys CloudForte, a comprehensive managed service offering to help accelerate the secure move of data and applications to the cloud; PowerSuite, a packaged software tool used by enterprise IT to monitor, analyze, troubleshoot and secure collaboration, and communications multi-platform environments; Unisys ClearPath Forward, a software operating environment for high-intensity enterprise computing; and Unisys Stealth security software, which enables trusted identities to access micro-segmented critical assets and safely communicate through secure and encrypted channels. In addition, the company provides industry solutions, which help law enforcement agencies solve crime; social services case workers assist families; travel and transportation companies manage freight and distribution; and financial institutions deliver omnichannel banking. It serves customers in the government, financial services, and commercial markets through direct sales force, distributors, resellers, and alliance partners. Unisys Corporation was founded in 1886 and is based in Blue Bell, Pennsylvania.

NYSE ended the session with Unisys Corporation New sliding 10.22% to $3.69 on Tuesday, after three consecutive sessions in a row of losses. NYSE rose 1.22% to $14,944.74, after three sequential sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Earnings Per Share

As for profitability, Unisys Corporation New has a trailing twelve months EPS of $-1.47.

More news about Unisys Corporation New.

8. Novavax (NVAX) – -8.64%

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

NASDAQ ended the session with Novavax falling 8.64% to $6.26 on Tuesday while NASDAQ rose 2.14% to $11,428.15.

Earnings Per Share

As for profitability, Novavax has a trailing twelve months EPS of $-7.27.

More news about Novavax.

9. Viad Corp (VVI) – -7.13%

Viad Corp operates as an experiential leisure travel, and live events and marketing services company in the United States, Canada, the United Kingdom, Continental Europe, the United Arab Emirates, and Iceland. It operates through two segments, Pursuit and GES. The Pursuit segment offers vertically integrated attractions and hospitality in destinations with a collection of attractions, lodges, and sightseeing tours. The GES is a full-service live events company that offers a range of services for exhibitions, conferences, brand experiences, and venues. In addition, the company offers a collection of travel experiences in recreational attractions, food and beverage, retail, and ground transportation services. It serves event organizers and corporate brand marketers directly, as well as through a distribution channel network that include tour operators, tour wholesalers, destination management companies, and retail travel agencies. Viad Corp was founded in 1926 and is headquartered in Scottsdale, Arizona.

NYSE ended the session with Viad Corp falling 7.13% to $20.33 on Tuesday, following the last session’s downward trend. NYSE jumped 1.22% to $14,944.74, after three sequential sessions in a row of losses, on what was an all-around up trend trading session today.

Earnings Per Share

As for profitability, Viad Corp has a trailing twelve months EPS of $-18.64.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.52%.

Sales Growth

Viad Corp’s sales growth is 27.6% for the current quarter and 7.3% for the next.

Volume

Today’s last reported volume for Viad Corp is 146663 which is 5.91% above its average volume of 138468.

Moving Average

Viad Corp’s worth is way under its 50-day moving average of $26.29 and way below its 200-day moving average of $30.91.

More news about Viad Corp.

10. Akebia Therapeutics (AKBA) – -6.91%

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, the European Union, Russia, China, Australia, Canada, the Middle East, and other countries; and Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Akebia Therapeutics falling 6.91% to $0.70 on Tuesday, after two successive sessions in a row of losses. NASDAQ jumped 2.14% to $11,428.15, following the last session’s upward trend on what was an all-around positive trend trading session today.

Earnings Per Share

As for profitability, Akebia Therapeutics has a trailing twelve months EPS of $-0.69.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -215.77%.

More news about Akebia Therapeutics.

Stay up to date with our winners and losers daily report